Metastatic Esophageal Squamous Cell Carcinoma

Metastatic Esophageal Squamous Cell Carcinoma is the indication for 4 drugs in DrugBank. It is covered by 11 curated, structured indications.

Also known as: Oesophageal squamous cell carcinoma metastatic · Esophageal Squamous Cell Carcinoma Metastatic · metastatic Oesophageal squamous cell carcinoma
Classified under: Digestive System Diseases
Neoplasms
Indicated drugs: Hyaluronidase (human recombinant)
Ipilimumab
Nivolumab
Tislelizumab

Resolves to

Vocabularies

MedDRA10015426UMLSC1142025

What you can answer from here — as of October 23, 2026

4Indicated drugsWith each drug's targets and mechanism

Listed above

11Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

14Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Metastatic Esophageal Squamous Cell Carcinoma share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.